Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

The cytokine IL-17A as a marker of treatment resistance in major depressive disorder?

Nothdurfter C, Milenkovic VM, Sarubin N, Hilbert S, Manook A, Weigl J, Almeqbaali K, Wetzel CH, Rupprecht R, Baghai TC.

Eur J Neurosci. 2019 Dec 2. doi: 10.1111/ejn.14636. [Epub ahead of print]

PMID:
31793127
2.

Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner.

Schmidtner AK, Slattery DA, Gläsner J, Hiergeist A, Gryksa K, Malik VA, Hellmann-Regen J, Heuser I, Baghai TC, Gessner A, Rupprecht R, Di Benedetto B, Neumann ID.

Transl Psychiatry. 2019 Sep 13;9(1):223. doi: 10.1038/s41398-019-0556-9.

3.

Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder.

Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Zill P, Manook A, Weigl J, Jooyandeh S, Nothdurfter C, von Schacky C, Bondy B, Rupprecht R.

Int J Mol Sci. 2018 Jun 12;19(6). pii: E1740. doi: 10.3390/ijms19061740.

4.

A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).

Ricken R, Wiethoff K, Reinhold T, Stamm TJ, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Laux G, Hauth I, Möller HJ, Heinz A, Bauer M, Adli M.

J Affect Disord. 2018 Mar 1;228:173-177. doi: 10.1016/j.jad.2017.11.051. Epub 2017 Nov 13.

PMID:
29253683
5.

Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression?

Milenkovic VM, Sarubin N, Hilbert S, Baghai TC, Stöffler F, Lima-Ojeda JM, Manook A, Almeqbaali K, Wetzel CH, Rupprecht R, Nothdurfter C.

Neuroimmunomodulation. 2017;24(2):106-112. doi: 10.1159/000479739. Epub 2017 Sep 13.

PMID:
28898872
6.

"I Am I and My Bacterial Circumstances": Linking Gut Microbiome, Neurodevelopment, and Depression.

Lima-Ojeda JM, Rupprecht R, Baghai TC.

Front Psychiatry. 2017 Aug 22;8:153. doi: 10.3389/fpsyt.2017.00153. eCollection 2017. Review.

7.

How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.

Adli M, Wiethoff K, Baghai TC, Fisher R, Seemüller F, Laakmann G, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Kronmüller KT, Smolka MN, Schlattmann P, Berger M, Ricken R, Stamm TJ, Heinz A, Bauer M.

Int J Neuropsychopharmacol. 2017 Sep 1;20(9):721-730. doi: 10.1093/ijnp/pyx043.

8.

Neurobiology of depression: A neurodevelopmental approach.

Lima-Ojeda JM, Rupprecht R, Baghai TC.

World J Biol Psychiatry. 2018 Aug;19(5):349-359. doi: 10.1080/15622975.2017.1289240. Epub 2017 Mar 3. Review.

PMID:
28155577
9.

The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men.

Sarubin N, Hilbert S, Naumann F, Zill P, Wimmer AM, Nothdurfter C, Rupprecht R, Baghai TC, Bühner M, Schüle C.

Eur Arch Psychiatry Clin Neurosci. 2017 Mar;267(2):123-133. doi: 10.1007/s00406-016-0722-5. Epub 2016 Aug 22.

PMID:
27549215
10.

Report of the WPA section of pharmacopsychiatry on the relationship of antiepileptic drugs with suicidality in epilepsy.

Fountoulakis KN, Gonda X, Baghai TC, Baldwin DS, Bauer M, Blier P, Gattaz W, Hasler G, Möller HJ, Tandon R, Vieta E, Kasper S.

Int J Psychiatry Clin Pract. 2015;19(3):158-67. doi: 10.3109/13651501.2014.1000930. Epub 2015 Apr 23. Review.

PMID:
25547437
11.

Characteristics and differences in treatment outcome of inpatients with chronic vs. episodic major depressive disorders.

Köhler S, Wiethoff K, Ricken R, Stamm T, Baghai TC, Fisher R, Seemüller F, Brieger P, Cordes J, Malevani J, Laux G, Hauth I, Möller HJ, Zeiler J, Heinz A, Bauer M, Adli M.

J Affect Disord. 2015 Mar 1;173:126-33. doi: 10.1016/j.jad.2014.10.059. Epub 2014 Nov 10.

PMID:
25462406
12.

The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.

Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC.

J Psychiatr Res. 2014 Jun;53:76-83. doi: 10.1016/j.jpsychires.2014.02.022. Epub 2014 Mar 11.

PMID:
24655586
13.

Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.

Nothdurfter C, Schmotz C, Sarubin N, Baghai TC, Laenger A, Lieb M, Bondy B, Rupprecht R, Schüle C.

J Psychiatr Res. 2014 May;52:15-20. doi: 10.1016/j.jpsychires.2014.01.013. Epub 2014 Jan 31.

PMID:
24513501
14.

Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression.

Sarubin N, Nothdurfter C, Schmotz C, Wimmer AM, Trummer J, Lieb M, Uhr M, Baghai TC, Wetter TC, Bühner M, Rupprecht R, Schüle C.

Psychoneuroendocrinology. 2014 Jan;39:141-51. doi: 10.1016/j.psyneuen.2013.10.008. Epub 2013 Oct 23.

PMID:
24275013
15.

Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene.

Myint AM, Bondy B, Baghai TC, Eser D, Nothdurfter C, Schüle C, Zill P, Müller N, Rupprecht R, Schwarz MJ.

Brain Behav Immun. 2013 Jul;31:128-33. doi: 10.1016/j.bbi.2013.04.003. Epub 2013 Apr 15.

PMID:
23597432
16.

Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.

Nothdurfter C, Baghai TC, Schüle C, Rupprecht R.

Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S107-12. doi: 10.1007/s00406-012-0352-5. Epub 2012 Aug 26. Review.

PMID:
22923187
17.

DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression.

Zill P, Baghai TC, Schüle C, Born C, Früstück C, Büttner A, Eisenmenger W, Varallo-Bedarida G, Rupprecht R, Möller HJ, Bondy B.

PLoS One. 2012;7(7):e40479. doi: 10.1371/journal.pone.0040479. Epub 2012 Jul 13.

18.

[Ketamine-induced vesicopathy].

Lieb M, Bader M, Palm U, Stief CG, Baghai TC.

Psychiatr Prax. 2012 Jan;39(1):43-5. doi: 10.1055/s-0031-1292789. Epub 2012 Jan 10. German.

PMID:
22234442
19.

Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ.

Eur Arch Psychiatry Clin Neurosci. 2012 Feb;262(1):13-22. doi: 10.1007/s00406-011-0274-7. Epub 2011 Nov 15.

PMID:
22083391
20.

General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Eur Arch Psychiatry Clin Neurosci. 2011 Nov;261 Suppl 3:207-45. doi: 10.1007/s00406-011-0259-6.

PMID:
22033583

Supplemental Content

Loading ...
Support Center